东兴证券：给予华峰化学买入评级

Core Viewpoint - Company faces short-term performance pressure due to declining product prices, but is expected to strengthen its integrated layout and scale advantages in the long term [1][2]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 12.137 billion yuan, a year-on-year decrease of 11.70%, and a net profit attributable to shareholders of 983 million yuan, down 35.23% year-on-year [1]. - The decline in revenue is attributed to lower market prices for key products such as spandex and adipic acid, with revenue from the three main business segments—chemical fibers, new chemical materials, and basic chemical products—falling by 9.43%, 8.82%, and 15.04% respectively [1]. Production Capacity and Scale Advantages - The company has a significant presence in the polyurethane industry, with spandex production capacity ranking second globally and first in China, along with the highest capacities for adipic acid and polyurethane raw materials in the country [1]. - Current spandex capacity stands at 325,000 tons, with an additional 150,000 tons under construction; adipic acid capacity is 1.355 million tons, and polyurethane raw material capacity is 520,000 tons [1]. Integrated Supply Chain Projects - The company is investing in upstream raw material projects, including a 1.1 million ton natural gas integrated project and a 240,000 ton PTMEG spandex deepening project, which are expected to enhance cost advantages for spandex production [2]. Profit Forecast and Investment Rating - The company is a leading player in spandex, adipic acid, and polyurethane raw materials, with clear advantages in scale, technology, and cost. Profit forecasts for 2025 to 2027 are net profits of 2.133 billion, 2.403 billion, and 2.664 billion yuan respectively, with corresponding EPS of 0.43, 0.48, and 0.54 yuan [2]. - The current stock price corresponds to P/E ratios of 18, 16, and 15 times for 2025, 2026, and 2027 respectively, maintaining a "strong buy" rating [2].